Pharma stockson Tuesday gained up to 20 per cent after the government relaxed export curbs on some pharma ingredients and medicines.
Shares of Morepen Laboratories zoomed 19.94 per cent, Nectar Lifesciences 19.93 per cent, Marksans Pharma 19.91 per cent, Vivimed Labs 19.38 per cent and RPG Life Sciences 18 per cent on the BSE.
Likewise, Aurobindo Pharma jumped 16.52 per cent, Laurus Labs gained 15.24 per cent, Indoco Remedies 13.94 per cent, Dr. Reddy's Laboratories 13.94 per cent and Torrent Pharmaceuticals 13.68 per cent.
AstraZeneca Pharma India stock jumped 12.08 per cent, Sun Pharmaceutical Industries 10.96 per cent, IPCA Laboratories 10.06 per cen, Jubilant Life Sciences 10 per cent and Natco Pharma 9.59 per cent.
The BSE Healthcare index jumped 8.95 per cent to close at 13,504.01.
"The government eased curbs on exports of 24 active pharmaceutical ingredients (APIs) and their formulations, which lifted the pharma index," Siddhartha Khemka, Head - Retail Research, Motilal Oswal Financial Services Ltd said.
The government on Monday relaxed export curbs on 24 pharma ingredients and medicines, including vitamin B1 and B12, according to an official notification.
The move assumes significance as certain pharma companies have raised concerns over these restrictions.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
